ClinicalTrials.gg
Sign In

Vividion Therapeutics, Inc. clinical trials

Acquired by Bayer, Aug 19, 2021 · source ↗

The registry lists 5 studies whose lead sponsor is Vividion Therapeutics, Inc.. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Before and after it joined Bayer

First submitted before Vividion Therapeutics, Inc. became part of Bayer
0
First submitted after Vividion Therapeutics, Inc. became part of Bayer
5
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Coming up

2 of Vividion Therapeutics, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

All 2

Add all 2 to your calendar (.ics) → With an account.

All 5 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now480%
  • Stopped early120%

Phase

  • Phase 14
  • Phase 21

Where

  • United States5
  • Spain4
  • Australia3
  • Korea, Republic of3
  • Malaysia2
  • Belgium2

Over the years

  1. 23
  2. 224
  3. 25
  4. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Vividion Therapeutics, Inc.5 studies

Something wrong with this grouping? Tell us on the Bayer page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All Bayer studies →